NCT07537257 2026-04-17
VEN+IDAC vs IDAC in AML
Guangdong Second Provincial General Hospital
Phase 2/3 Enrolling by invitation
Clinical Trials
20 trialsNCT06788509 2026-04-13
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Phase 1 Enrolling by invitation
NCT07517510 2026-04-08
HVA-MPAL
Guangdong Second Provincial General Hospital
Phase 2 Enrolling by invitation
NCT06795126 2026-03-27
Little NIRVANA for Pediatric Pain and Anxiety
Nationwide Children's Hospital
Phase NA Enrolling by invitation
NCT06773936 2026-03-04
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
Phase 2 Enrolling by invitation
NCT04093570 2025-10-31
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Taiho Oncology, Inc.
Phase 2 Enrolling by invitation
NCT07014462 2025-10-06
DLIT-AML
University of Vermont
Phase 1 Enrolling by invitation
NCT07172191 2025-09-15
HEMAT-FMT
Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases
Phase NA Enrolling by invitation
NCT07168486 2025-09-11
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
University of Maryland, Baltimore
Phase 1 Enrolling by invitation
NCT05673551 2025-06-19
VR-PAT During Home Burn Dressings - Multisite
Nationwide Children's Hospital
Phase NA Enrolling by invitation
NCT06697327 2025-05-14
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Anhui Medical University
Phase NA Enrolling by invitation
NCT02646839 2025-05-04
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Pediatric Transplantation & Cellular Therapy Consortium
Phase 2 Enrolling by invitation
NCT04836390 2025-05-04
EXCEL
Pediatric Transplantation & Cellular Therapy Consortium
Phase 2 Enrolling by invitation
NCT03507842 2025-03-17
A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.
Asan Medical Center
Phase 3 Enrolling by invitation
NCT06560879 2025-03-14
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia
National Institute of Pediatrics, Mexico
Phase 2 Enrolling by invitation
NCT05674539 2025-02-10
Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3 Enrolling by invitation
NCT06762431 2025-01-07
VTB-CLL002
Vitebsk Regional Clinical Cancer Centre
Phase 1/2 Enrolling by invitation
NCT06711679 2024-12-02
Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia
Tongji Hospital
Phase 4 Enrolling by invitation
NCT06544109 2024-08-09
Ven APL
The First Affiliated Hospital of Soochow University
Phase 2/3 Enrolling by invitation
NCT06412692 2024-05-14
Motivational Interviewing in Adolescents With Epilepsy
Izmir Katip Celebi University
Phase NA Enrolling by invitation